Alkermes (ALKS) Selling, General & Administrative (2010 - 2026)
Alkermes (ALKS) posted Selling, General & Administrative of $217.63 million for Q2 2026, up 27.4% from $170.85 million a year earlier but down 17.8% from the prior quarter.
Powered by 
Analysis
Alkermes (ALKS) Selling, General & Administrative (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Alkermes was $841.19 million, up 31.5% year-over-year; for FY2025, it was $701.52 million, up 8.7% from FY2024.
- Annual Selling, General & Administrative shows a five-year compound annual growth rate of 5.4% (FY2020 to FY2025).
- In prior years, Alkermes' Selling, General & Administrative was $645.24 million in FY2024 (-6.5%), $689.75 million in FY2023 (+16.8%), $590.75 million in FY2022 (+7.5%) and $549.61 million in FY2021 (+2.0%).
- Quarterly Selling, General & Administrative has run from a low of $136.21 million in Q3 2021 to a high of $264.59 million in Q1 2026 over five years.
- On a year-over-year basis, Selling, General & Administrative has increased in each of the last five quarters, with growth averaging 12.9% over the last eight quarters.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q1 2026, with growth of 54.1%; the weakest was Q2 2024, with a decline of 14.1%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $264.59 million (Q1 2026), $187.2 million (Q4 2025) and $171.77 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 582.20 Mn |
| 10 | Alkermes | 6.79 Bn | 3.92 Bn | 397.90 Mn | 217.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 217.63 Mn |
| Mar 31, 2026 | 264.59 Mn |
| Dec 31, 2025 | 187.20 Mn |
| Sep 30, 2025 | 171.77 Mn |
| Jun 30, 2025 | 170.85 Mn |
| Mar 31, 2025 | 171.70 Mn |
| Dec 31, 2024 | 146.99 Mn |
| Sep 30, 2024 | 150.38 Mn |
| Jun 30, 2024 | 168.11 Mn |
| Mar 31, 2024 | 179.75 Mn |
| Dec 31, 2023 | 169.79 Mn |
| Sep 30, 2023 | 156.37 Mn |
| Jun 30, 2023 | 195.76 Mn |
| Mar 31, 2023 | 167.83 Mn |
| Dec 31, 2022 | 142.55 Mn |
| Sep 30, 2022 | 152.78 Mn |
| Jun 30, 2022 | 150.38 Mn |
| Mar 31, 2022 | 145.05 Mn |
| Dec 31, 2021 | 149.04 Mn |
| Sep 30, 2021 | 136.21 Mn |
API Access
Alkermes Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();